Boomfish Wealth Group’s AbbVie ABBV Stock Holding History

Boomfish Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$298K	Buy	1,371 +7	+0.5%	+$1.55K	0.16%	77
2025 Q4	$312K	Sell	1,364 -27	-2%	-$6.15K	0.17%	78
2025 Q3	$322K	Sell	1,391 -4	-0.3%	-$815	0.17%	78
2025 Q2	$259K	Buy	1,395 +4	+0.3%	+$743	0.15%	79
2025 Q1	$291K	Buy	1,391 +30	+2%	+$5.83K	0.19%	74
2024 Q4	$242K	Sell	1,361 -37	-3%	-$6.8K	0.15%	84
2024 Q3	$276K	Sell	1,398 -54	-4%	-$10.1K	0.17%	83
2024 Q2	$249K	Sell	1,452 -16	-1%	-$2.65K	0.16%	83
2024 Q1	$267K	Buy	1,468 +4	+0.3%	+$689	0.18%	81
2023 Q4	$227K	Buy	+1,464	New	+$213K	0.16%	81

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boomfish Wealth Group's ABBV Position: Q1 2026 in Review

Boomfish Wealth Group increased its AbbVie (ABBV) stake by 0.51% in Q1 2026, buying an estimated $1.55K and bringing the position to 1,371 shares worth $298K. The position accounts for 0.16% of the portfolio, ranked #77.

Boomfish Wealth Group first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $322K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Boomfish Wealth Group held 1,371 shares of AbbVie worth $298K as of Q1 2026.
Boomfish Wealth Group bought 7 AbbVie shares in Q1 2026, an estimated $1.55K.
AbbVie made up 0.16% of Boomfish Wealth Group's portfolio in Q1 2026, its #77 holding.
Boomfish Wealth Group first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Boomfish Wealth Group's AbbVie position peaked at $322K in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Boomfish Wealth Group's 13F filing for Q1 2026, filed 22 Apr 2026.